Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jawahar Mehta to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Jawahar Mehta has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.

 
Connection Strength
  
 
 
5.579
  
  1. Alhallak I, Paydak H, Mehta JL. Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis. Curr Probl Cardiol. 2023 Sep; 48(9):101810.
    View in: PubMed
    Score: 0.816
  2. Rochlani Y, Kattoor AJ, Pothineni NV, Palagiri RDR, Romeo F, Mehta JL. Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention. Am J Cardiol. 2017 Oct 01; 120(7):1122-1128.
    View in: PubMed
    Score: 0.544
  3. Deshmukh A, Mehta JL. Statins and renal disease: friend or foe? Curr Atheroscler Rep. 2011 Feb; 13(1):57-63.
    View in: PubMed
    Score: 0.348
  4. Kang BY, Wang W, Palade P, Sharma SG, Mehta JL. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine. J Cardiovasc Pharmacol. 2009 Oct; 54(4):327-34.
    View in: PubMed
    Score: 0.317
  5. Kang BY, Mehta JL. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1. J Cardiovasc Pharmacol Ther. 2009 Dec; 14(4):283-91.
    View in: PubMed
    Score: 0.315
  6. Khaidakov M, Wang W, Khan JA, Kang BY, Hermonat PL, Mehta JL. Statins and angiogenesis: is it about connections? Biochem Biophys Res Commun. 2009 Sep 25; 387(3):543-7.
    View in: PubMed
    Score: 0.313
  7. Sukhija R, Prayaga S, Marashdeh M, Bursac Z, Kakar P, Bansal D, Sachdeva R, Kesan SH, Mehta JL. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med. 2009 Mar; 57(3):495-9.
    View in: PubMed
    Score: 0.305
  8. Sukhija R, Bursac Z, Kakar P, Fink L, Fort C, Satwani S, Aronow WS, Bansal D, Mehta JL. Effect of statins on the development of renal dysfunction. Am J Cardiol. 2008 Apr 01; 101(7):975-9.
    View in: PubMed
    Score: 0.282
  9. Sinha AK, Mehta JL. Modulation of atherosclerosis, blood pressure and arterial elasticity by statins. Adv Cardiol. 2007; 44:315-330.
    View in: PubMed
    Score: 0.262
  10. Mehta JL, Bursac Z, Hauer-Jensen M, Fort C, Fink LM. Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population. Am J Cardiol. 2006 Oct 01; 98(7):923-8.
    View in: PubMed
    Score: 0.255
  11. Sarkar K, Sinha AK, Mehta JL. The role of statins in endothelial dysfunction in hypertension. Curr Opin Cardiol. 2006 Jul; 21(4):316-21.
    View in: PubMed
    Score: 0.253
  12. Chen J, Mehta JL. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am J Physiol Heart Circ Physiol. 2006 Oct; 291(4):H1738-45.
    View in: PubMed
    Score: 0.251
  13. Chen J, Li D, Schaefer RF, Mehta JL. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis. J Cardiovasc Pharmacol. 2004 Oct; 44(4):446-52.
    View in: PubMed
    Score: 0.224
  14. Li D, Mehta JL. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction. Endothelium. 2003; 10(1):17-21.
    View in: PubMed
    Score: 0.199
  15. Kaushal V, Kohli M, Mehta P, Mehta JL. Potential anticancer effects of statins: fact or fiction? Endothelium. 2003; 10(1):49-58.
    View in: PubMed
    Score: 0.199
  16. Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther. 2002 Aug; 302(2):601-5.
    View in: PubMed
    Score: 0.193
  17. Mehta JL, Li DY, Chen HJ, Joseph J, Romeo F. Inhibition of LOX-1 by statins may relate to upregulation of eNOS. Biochem Biophys Res Commun. 2001 Dec 14; 289(4):857-61.
    View in: PubMed
    Score: 0.185
  18. Mehta JL, Bursac Z, Mehta P, Bansal D, Fink L, Marsh J, Sukhija R, Sachdeva R. Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals. Am J Cardiol. 2010 Apr 01; 105(7):1019-23.
    View in: PubMed
    Score: 0.081
  19. Clementi F, Di Luozzo M, Mango R, Luciani G, Trivisonno A, Pizzuto F, Martuscelli E, Mehta JL, Romeo F. Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis. J Cardiovasc Med (Hagerstown). 2009 Mar; 10(3):231-7.
    View in: PubMed
    Score: 0.076
  20. Chen J, Li D, Schaefer R, Mehta JL. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis. 2006 Feb; 184(2):295-301.
    View in: PubMed
    Score: 0.059
  21. Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D, Mehta JL, Ponnappan U, Lin P, Fink LM, Hauer-Jensen M. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis. 2003 Sep; 14(6):575-85.
    View in: PubMed
    Score: 0.052
  22. Li D, Singh RM, Liu L, Chen H, Singh BM, Kazzaz N, Mehta JL. Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovasc Res. 2003 Jan; 57(1):238-43.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.